Deoxycytidine kinase inhibitors

US9598404B2 · kind B2 · utility

Assignees

• The Regents of the University of California · US
• The Board of Trustees of the University of Illinois · US

Inventors

• Caius G. Radu · Los Angeles, US
• Zheng Li · Quaker Hill, US
• Raymond M. Gipson · Los Angeles, US
• Jue Wang · Los Angeles, US
• Nagichettiar Satyamurthy · Los Angeles, US
• Arnon Lavie · Chicago, US
• Jennifer M. Murphy · Los Angeles, US
• David A. Nathanson · Los Angeles, US
• Michael E. Jung · Los Angeles, US

Key dates

• Filing date: Jan 11, 2016
• Grant date: Mar 21, 2017
• Expiry date: Jan 11, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/05
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are compounds that bind to dCK and methods for treating cancer.